NCT01681186 - A Study of LY2940680 in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Healthy Participants

Interventions

DRUG

LY2940680 Capsule(s) (Reference)

Administered orally as a capsule(s)

DRUG

LY2940680 Tablet (Test)

Administered orally as a tablet

DRUG

Lansoprazole

Administered orally as a capsule

DRUG

Placebo Capsule(s)

Administered orally as a capsule(s)

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY